Sponsor or institution

Clinical trials and research at Sinovac Biotech Co., Ltd

• 13Clinical trials
• 1New in 30 days
• 3Countries

Newest trials

All recruiting trials (13)

• How long immunity lasts after inactivated hepatitis A vaccine

  This study tests if immunity from the inactivated hepatitis A vaccine lasts up to 20 years in adults who completed the vaccination course in a prior trial.

  Recruiting Sinovac Biotech Co., Ltd · Changzhou, Jiangsu · NCT07889219

• Hepatitis A vaccine study to see how well different doses work in adults and kids

  This Phase 3 study tests two doses of Healive for safety and immune response in adults and children, with adults receiving a single actively treated dose and children randomly receiving Healive or another HepA vaccine.

  Recruiting Phase 3 Sinovac Biotech Co., Ltd · Hanoi · NCT07793227

• Meningococcal vaccine for children 12–23 months old (Group ACYW135)

  This study tests whether the new Group ACYW135 meningococcal vaccine in healthy children aged 12 to 23 months can provoke a similar immune response and has an acceptable safety profile compared with a licensed vaccine.

  Recruiting at 2 sites Phase 3 Sinovac Biotech Co., Ltd · Nanning, Guangxi and 1 other locations · NCT07505836

• Group ACYW135 meningococcal vaccine in children 6-11 months

  This trial tests whether the investigational meningococcal vaccine in healthy infants aged 6 to 11 months can provoke a strong immune response with good safety compared with a licensed vaccine.

  Recruiting at 2 sites Phase 3 Sinovac Biotech Co., Ltd · Nanning, Guangxi and 1 other locations · NCT07505823

• Meningococcal vaccine in infants aged 3-5 months

  This trial tests a new group ACYW135 meningococcal vaccine in healthy babies aged 3 to 5 months to see if it triggers a strong immune response and how safe it is, with a booster given at 12 months.

  Recruiting at 2 sites Phase 3 Sinovac Biotech Co., Ltd · Nanning, Guangxi and 1 other locations · NCT07505810

• Sequential vaccination with Sabin-strain and wild-strain inactivated polio vaccines

  It will test different combinations and injection routes of inactivated polio vaccines in healthy 2-month-old infants to see if they produce strong antibody protection with good safety.

  Recruiting at 3 sites Phase 4 Sinovac Biotech Co., Ltd · Kawit, Cavite and 2 other locations · NCT07457060

• Lyophilized shingles mRNA vaccine safety and immune response

  This trial will test a lyophilized mRNA vaccine to see if it is safe and produces immune responses in adults aged 40 years and older.

  Recruiting Phase 1/2 Sinovac Biotech Co., Ltd · Xinjiang · NCT07400003

• One-dose Sabin inactivated polio vaccine (sIPV) in adolescents and adults versus three-dose DTaP‑IPV‑Hib in infants

  This will try one dose of Sabin inactivated poliovirus vaccine (sIPV) in people aged 7–50 to see if it gives similar antibody protection and safety as three doses of DTaP‑IPV‑Hib given to infants.

  Recruiting at 3 sites Phase 4 Sinovac Biotech Co., Ltd · Dingxi, Gansu and 2 other locations · NCT07354269

• 24‑valent pneumococcal conjugate vaccine (PCV24) for children aged 2 months to 5 years

  This will test whether Sinovac's 24‑valent pneumococcal vaccine (PCV24) is safe and triggers protective immune responses in children aged 2 months to 5 years, compared with the licensed Prevnar13 vaccine.

  Recruiting at 3 sites Phase 2 Sinovac Biotech Co., Ltd · Huanggang, Hubei and 2 other locations · NCT07300644

• Evaluating a new oral rotavirus vaccine in infants

  This study is testing a new oral rotavirus vaccine in healthy infants aged 6 to 12 weeks to see if it is safe and effective at building immunity.

  Recruiting Phase 2 Sinovac Biotech Co., Ltd · Wuhan, Hubei · NCT06967272

• PCV24 vaccine for infants aged 2 to 23 months

  This will test whether the new 24‑valent PCV24 vaccine is safe and produces protective immune responses in healthy infants aged 2 to 23 months, compared with the standard Prevnar13 vaccine.

  Recruiting Phase 1 Sinovac Biotech Co., Ltd · Jinan, Shandong and 1 other locations · NCT06800261

• Evaluating a new vaccine for Hand, Foot, and Mouth Disease in young children

  This study is testing a new vaccine to see if it can help protect young children from Hand, Foot, and Mouth Disease.

  Recruiting at 4 sites Phase 3 Sinovac Biotech Co., Ltd · Hefei, Anhui and 3 other locations · NCT06734832

• Testing a new pneumococcal vaccine in young children

  This study is testing a new pneumococcal vaccine for healthy children aged 2 months to 5 years to see if it works well and is safe compared to an existing vaccine.

  Recruiting Phase 3 Sinovac Biotech Co., Ltd · Zhengzhou, Henan · NCT06617715

Quick answers

How many clinical trials run by Sinovac Biotech Co., Ltd are recruiting right now?

13, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in China (11 trials), Philippines (1 trial), Vietnam (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 6, Phase 2: 2, Phase 4: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →